Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J J ; Barrios, C H ; Kim, T M ; Cosgriff, T ; Srimuninnimit, V ; Pittman, K ; Sabbatini, R ; Rha, S Y ; Flaig, T W ; Page, R D ; Beck, J T ; Cheung, F ; Yadav, S ; Patel, P ; Geoffrois, L ; Niolat, J ; Berkowitz, N ; Marker, M ; Chen, D ; Motzer, R J

England: Oxford University Press

Texto completo disponível

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

Elsevier Ltd

Texto completo disponível

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

England: Elsevier Ltd

Texto completo disponível

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Basso, U. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Re, G.L.o. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Elsevier Ltd

Texto completo disponível

Clinical outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequences in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Maruzzo, M. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Lo Re, G. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Texto completo disponível

Retrospective observational study of Vinflunine (VFL) in patients (pts) with transitional cell carcinoma of the urothelial tract (TCCU): final results of a real world population study (MOVIE-GOIRC01/2014 trial)

Passalacqua, R. ; Lazzarelli, S. ; Montironi, R. ; Pignata, S. ; De Giorgi, U. ; Bernardo, A. ; Ceresoli, G.L. ; Delconte, G. ; Donini, M. ; Iezzi, E. ; Maiello, E. ; Nolè, F. ; Panni, S. ; Perrucci, B. ; Rondini, E. ; Sabbatini, R. ; Sequino, M. ; Tonini, G. ; Zucali, P. ; Caminiti, C.

Texto completo disponível

Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents

Grassi, P. ; Grunwald, V. ; Melichar, B. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Ortega, C. ; Santoni, M. ; Derosa, L. ; Porcu, L. ; Ratta, R. ; Mennitto, A. ; Verzoni, E. ; de Braud, F. ; Porta, C. ; Escudier, B. ; Procopio, G.

Texto completo disponível

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Lorusso, D. ; Scambia, G. ; Pignata, S. ; Sorio, R. ; Amadio, G. ; Lepori, S. ; Mosconi, A. ; Pisano, C. ; Mangili, G. ; Maltese, G. ; Sabbatini, R. ; Artioli, G. ; Gamucci, T. ; Di Napoli, M. ; Capoluongo, E. ; Ludovini, V. ; Raspagliesi, F. ; Ferrandina, G.

England: Elsevier Ltd

Texto completo disponível

Effectiveness and possible molecular factors predictive of clinical outcomes in patients with transitional cell carcinoma of the urothelial tract (TCCU) treated with VInfluninE: a multicenter retrospective study (MOVIE) of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Donini, M. ; Passalacqua, R. ; Montironi, R. ; Lazzarelli, S. ; Perrucci, B. ; Nole', F. ; Ceresoli, G.L. ; Pignata, S. ; Torriccelli, F. ; Tonini, G. ; Doni, L. ; Bernardo, A. ; Marcomini, B. ; Necchi, A. ; Betri, E. ; Degiorgi, U. ; Sabbatini, R. ; Rondini, E. ; Maiello, E. ; Caminiti, C.

Texto completo disponível

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Bracarda, S. ; Iacovelli, R. ; Boni, L. ; Rizzo, M. ; Derosa, L. ; Rossi, M. ; Galli, L. ; Procopio, G. ; Sisani, M. ; Longo, F. ; Santoni, M. ; Morelli, F. ; Di Lorenzo, G. ; Altavilla, A. ; Porta, C. ; Camerini, A. ; Escudier, B. ; Martignetti, Angelo ; Ricotta, Riccardo ; Gasparro, Donatello ; Sabbatini, Roberto ; Ceresoli, Giovanni Luca ; Mosca, Alessandra ; Santini, Daniele ; Caserta, Claudia ; Cavanna, Luigi ; Massari, Francesco ; Sava, Teodoro ; Boni, Corrado ; Verzoni, Elena ; Cartenì, Giacomo ; Hamzaj, Alketa

England: Elsevier Ltd

Texto completo disponível